[go: up one dir, main page]

EP0423315A4 - Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine - Google Patents

Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Info

Publication number
EP0423315A4
EP0423315A4 EP19900907743 EP90907743A EP0423315A4 EP 0423315 A4 EP0423315 A4 EP 0423315A4 EP 19900907743 EP19900907743 EP 19900907743 EP 90907743 A EP90907743 A EP 90907743A EP 0423315 A4 EP0423315 A4 EP 0423315A4
Authority
EP
European Patent Office
Prior art keywords
antigen peptide
dendritic polymer
system useful
multiple antigen
peptide system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900907743
Other versions
EP0423315A1 (en
Inventor
James P. Tam
Fidel P. Zavala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
New York University NYU
Original Assignee
Rockefeller University
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University, New York University NYU filed Critical Rockefeller University
Publication of EP0423315A1 publication Critical patent/EP0423315A1/en
Publication of EP0423315A4 publication Critical patent/EP0423315A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP19900907743 1989-04-12 1990-04-10 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine Withdrawn EP0423315A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33685289A 1989-04-12 1989-04-12
US336852 1994-11-08

Publications (2)

Publication Number Publication Date
EP0423315A1 EP0423315A1 (en) 1991-04-24
EP0423315A4 true EP0423315A4 (en) 1991-11-13

Family

ID=23317953

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900907743 Withdrawn EP0423315A4 (en) 1989-04-12 1990-04-10 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Country Status (5)

Country Link
EP (1) EP0423315A4 (en)
JP (1) JPH03503539A (en)
AU (1) AU5649290A (en)
CA (1) CA2031197A1 (en)
WO (1) WO1990011778A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
IT1241395B (en) * 1990-04-02 1994-01-10 Eniricerche Spa IMMUNOGENIC COMPOUNDS, THE PROCEDURE FOR THEIR SYNTHESIS AND THEIR USE FOR THE PREPARATION OF ANIMALARY VACCINES
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
KR950700081A (en) * 1992-02-11 1995-01-16 W 로우 죤 Dual Carrier Immunogenic Constructs
US5599912A (en) * 1993-09-10 1997-02-04 Coretech, Inc. Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances
FI955320L (en) * 1994-03-07 1995-11-24 Dow Chemical Co Bioactive and/or targeted dendritic conjugates
US5591717A (en) * 1994-04-06 1997-01-07 Rojko; Jennifer L. Branched apogenic peptide for inducing apoptosis
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
GB2308363A (en) * 1995-12-22 1997-06-25 Courtaulds Coatings Dendritic Polymers
AU5812898A (en) * 1996-12-24 1998-08-03 New York University Polyoxime-based anti-malarial vaccines
CN1244126A (en) * 1997-01-21 2000-02-09 纽约大学 Universal T-cell epitopes for anti-malarial vaccines
FR2772770B1 (en) * 1997-12-19 2000-01-28 Oreal NOVEL COMPOUNDS SELECTED AMONG HYPERBRANCHED POLYMERS AND DENDRIMERS HAVING A PARTICULAR GROUPING, METHOD OF PREPARATION, USE AND COMPOSITIONS COMPRISING THE SAME
ITRM20010563A1 (en) * 2001-09-14 2003-03-14 Univ Siena MULTIPLE ANTIGEN PEPTIDES AS ANTIDOTES IN SNAKE POISON POISONING.
DK1940916T3 (en) 2005-10-25 2017-03-20 Starpharma Pty Ltd MACROMOLECULAR COMPOUNDS WITH CONTROLLED STOCHIOMETRY
US11091786B2 (en) 2015-10-01 2021-08-17 Nanyang Technological University Butelase-mediated peptide ligation
WO2017120098A1 (en) * 2016-01-06 2017-07-13 University Of Florida Research Foundation, Inc. Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles
WO2018017954A1 (en) * 2016-07-21 2018-01-25 Rutgers, The State University Of New Jersey Antimicrobial cationic systems and methods of use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2154240A (en) * 1984-01-27 1985-09-04 Univ New York Immunodominant epitope of the circumsporozoite surface protein
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
EP0275196A2 (en) * 1987-01-14 1988-07-20 Manuel E. Patarroyo Protein copolymer malaria vaccine
EP0343460A2 (en) * 1988-05-24 1989-11-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft P. falciparum CS-peptides as universal T-cell epitope

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289872A (en) * 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2154240A (en) * 1984-01-27 1985-09-04 Univ New York Immunodominant epitope of the circumsporozoite surface protein
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
EP0275196A2 (en) * 1987-01-14 1988-07-20 Manuel E. Patarroyo Protein copolymer malaria vaccine
EP0343460A2 (en) * 1988-05-24 1989-11-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft P. falciparum CS-peptides as universal T-cell epitope

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9011778A1 *

Also Published As

Publication number Publication date
CA2031197A1 (en) 1990-10-13
AU5649290A (en) 1990-11-05
WO1990011778A1 (en) 1990-10-18
EP0423315A1 (en) 1991-04-24
JPH03503539A (en) 1991-08-08

Similar Documents

Publication Publication Date Title
EP0423315A4 (en) Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
HU9201966D0 (en) An improved vaccine of meningococcus-polysaccharide conjunction
HUT57264A (en) Process for producing turkey- recombinant herpes virus and living vector vaccine from them
GB2234896B (en) Processes for the preparation of sustained release formulations of water soluble peptides
AU5739190A (en) Introduction system for locating compatible persons
IT8922355A0 (en) SYNTHETIC PEPTIDES USEFUL AS UNIVERSAL CARRIERS FOR THE PREPARATION OF IMMUNOGENIC CONJUGATES AND THEIR USE FOR THE DEVELOPMENT OF SYNTHETIC VACCINES
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
IL92813A0 (en) Condensed quinoline system compound and process for preparation thereof
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
IL94558A0 (en) Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
PH25798A (en) Protein copolymer malaria vaccine
FI915702A7 (en) Peptides and antibodies derived from them for the determination of vaccination against HTLV-1 infection
ZA88197B (en) Protein copolymer malaria vaccine
GB8918689D0 (en) 25/15 vaccine
GB8915572D0 (en) Use of bluetongue virus proteins as vaccine components
AP9000165A0 (en) Vaccine composition
AU630186B2 (en) Canine corona virus vaccine
IT8921935A0 (en) PROCEDURE FOR THE PREPARATION OF ETHYLENE-PROPYLENE COPOLYMERS
HU902652D0 (en) Process for the preparation of malaria vaccine
EP0431980A3 (en) Preparation of high molecular weight organo-polysiloxane
AU8067187A (en) Method for preparation of tastable matters consisting mainly of low molecular weight peptides
GB2248186B (en) Preparation of vaccines
EP0486507A4 (en) Anthelmintic non-living vaccine
AU2971692A (en) Flystrike antigen and vaccine and method for preparation
FR2648712B1 (en) VACCINE AGAINST BOVINE LEUKEMIA VIRUS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910923

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19921105